We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+9.34%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$9.03B
AUM Growth
+$6.6B
Cap. Flow
+$1.53B
Cap. Flow %
16.94%
Top 10 Hldgs %
64.29%
Holding
5,395
New
546
Increased
3,017
Reduced
1,240
Closed
466

Sector Composition

Rank Sector Weight
1 Technology 6.44%
2 Industrials 4.65%
3 Healthcare 4.47%
4 Consumer Discretionary 4.32%
5 Financials 3.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AFI
3576
DELISTED
Armstrong Flooring, Inc.
AFI
$46K ﹤0.01%
13,598
+2,742
+25% +$9.57K
BNS icon
3577
Scotiabank
BNS
$112B
$45K ﹤0.01%
1,100
-5,784
-84% -$243K
EPP icon
3578
iShares MSCI Pacific ex Japan ETF
EPP
$2.24B
$45K ﹤0.01%
+1,102
New +$45.6K
KWY
3579
Kingsway Corp
KWY
$285M
$45K ﹤0.01%
+15,385
New +$41.9K
FIRY
3580
Firy Inc
FIRY
$148M
$45K ﹤0.01%
+185
New +$42.5K
TLRY icon
3581
Tilray
TLRY
$636M
$45K ﹤0.01%
925
+820
+781% +$54.8K
ARCH
3582
DELISTED
Arch Resources, Inc.
ARCH
$45K ﹤0.01%
1,070
-17,978
-94% -$638K
DBC icon
3583
Invesco DB Commodity Index Tracking Fund
DBC
$1.73B
$44K ﹤0.01%
3,386
+2,337
+223% +$30.5K
EWG icon
3584
iShares MSCI Germany ETF
EWG
$1.68B
$44K ﹤0.01%
1,520
-19,796
-93% -$580K
PHG icon
3585
Philips
PHG
$26.7B
$44K ﹤0.01%
1,157
-368
-24% -$14.8K
RYTM icon
3586
Rhythm Pharmaceuticals
RYTM
$7.95B
$44K ﹤0.01%
2,017
-767
-28% -$17.6K
DCOY
3587
Decoy Therapeutics
DCOY
$1.9M
$44K ﹤0.01%
+1
New +$39.6K
TU icon
3588
Telus
TU
$15.4B
$44K ﹤0.01%
+2,500
New +$44.4K
DVD
3589
DELISTED
Dover Motorsports
DVD
$44K ﹤0.01%
+30,947
New +$44.6K
STAY
3590
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
$44K ﹤0.01%
3,681
-10,595
-74% -$127K
CRHM
3591
DELISTED
CRH Medical Corporation
CRHM
$44K ﹤0.01%
20,330
+6,112
+43% +$14.3K
VIE
3592
DELISTED
Viela Bio, Inc. Common Stock
VIE
$44K ﹤0.01%
1,554
-2,641
-63% -$93.4K
ECH icon
3593
iShares MSCI Chile ETF
ECH
$1.04B
$43K ﹤0.01%
1,772
+1,697
+2,263% +$44.3K
MUX icon
3594
McEwen Inc
MUX
$1.15B
$43K ﹤0.01%
4,040
+3,180
+370% +$38.5K
NTST
3595
NETSTREIT Corp
NTST
$2.1B
$43K ﹤0.01%
+2,357
New +$42.6K
PRQR icon
3596
ProQR Therapeutics
PRQR
$271M
$43K ﹤0.01%
8,959
+7,639
+579% +$40K
RCEL icon
3597
Avita Medical
RCEL
$243M
$43K ﹤0.01%
1,698
+1,422
+515% +$35.4K
SBSI icon
3598
Southside Bancshares
SBSI
$986M
$43K ﹤0.01%
1,748
-1,857
-52% -$50.2K
TBBK icon
3599
The Bancorp
TBBK
$2.84B
$43K ﹤0.01%
5,008
-1,860
-27% -$17.1K
TUSK icon
3600
Mammoth Energy Services
TUSK
$160M
$43K ﹤0.01%
26,769
+23,529
+726% +$34.7K

Similar funds

Tower Research Capital (TRC)'s Q3 2020 Portfolio in Review

As of Q3 2020, Tower Research Capital (TRC) held 5,395 positions worth $9.03B, up 271% from $2.44B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Tower Research Capital (TRC) deployed $1.53B of net new capital in Q3 2020, opening 546 new positions and adding to 3,017 existing holdings. Its largest new stake was iShares Biotechnology ETF: 34,723 shares worth $4.7M.

By sector, the portfolio is most concentrated in Technology at 6.4% of assets, down from 12% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $38.5M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2020 buy was iShares Biotechnology ETF: 34,723 shares worth $4.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $487M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $38.5M.
  • Tower Research Capital (TRC) fully exited iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2020, selling an estimated $51.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 64% of its $9.03B portfolio in Q3 2020.
  • Tower Research Capital (TRC) opened 546 new positions and closed 466 in Q3 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 271% quarter-over-quarter to $9.03B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2020, filed 16 Nov 2020.